42 related articles for article (PubMed ID: 6141286)
21. [Mechanism of platelet aggregation inhibition].
Abiko Y; Ashida S
Rinsho Byori; 1979; Suppl 40():169-80. PubMed ID: 233105
[No Abstract] [Full Text] [Related]
22. [Present status and prospects of platelet inhibitors].
Yasunaga K
Rinsho Ketsueki; 1976 Jun; 17(6):590-9. PubMed ID: 184313
[No Abstract] [Full Text] [Related]
23. Calcium-calmodulin-stimulated and cyclic-GMP-specific phosphodiesterases. Tissue distribution, drug sensitivity, and regulation of cyclic GMP levels.
Ahn HS; Crim W; Pitts B; Sybertz EJ
Adv Second Messenger Phosphoprotein Res; 1992; 25():271-88. PubMed ID: 1313262
[No Abstract] [Full Text] [Related]
24. Cyclic GMP in cell function.
Tremblay J; Gerzer R; Hamet P
Adv Second Messenger Phosphoprotein Res; 1988; 22():319-83. PubMed ID: 2906250
[No Abstract] [Full Text] [Related]
25. Distribution and regulation of cyclic GMP in the central nervous system.
Ferrendelli JA
Adv Cyclic Nucleotide Res; 1978; 9():453-64. PubMed ID: 27081
[No Abstract] [Full Text] [Related]
26. [Cyclic nucleotides and blood platelet functions].
Kuramoto A
Nihon Rinsho; 1978 Dec; 36(12):3813-8. PubMed ID: 34743
[No Abstract] [Full Text] [Related]
27. Cyclic nucleotides and the central effects of opiates: an overview of current research.
Rosenfeld GC; Strada SJ; Robison GA
Adv Biochem Psychopharmacol; 1979; 20():261-79. PubMed ID: 38640
[No Abstract] [Full Text] [Related]
28. [Biochemical mechanism of blood platelet release reaction, aggregation and adhesiveness].
Hidaka H; Ikukawa S
Nihon Rinsho; 1978 Dec; 36(12):3798-804. PubMed ID: 219272
[No Abstract] [Full Text] [Related]
29. [Cyclic nucleotides and blood platelet function].
Xu SH
Sheng Li Ke Xue Jin Zhan; 1992 Oct; 23(4):318-22. PubMed ID: 1338807
[No Abstract] [Full Text] [Related]
30. Stimulus-response coupling mechanisms in human platelets.
Rink TJ
Agents Actions Suppl; 1986; 20():147-69. PubMed ID: 3028101
[No Abstract] [Full Text] [Related]
31. [Medical progress. Blood platelets and cardiovascular diseases. I. Platelet biology].
Jobin F
Union Med Can; 1976 Feb; 105(2):231-5. PubMed ID: 186918
[No Abstract] [Full Text] [Related]
32. Radioimmunoassay for the cyclic nucleotides.
Steiner AL
Pharmacol Rev; 1973 Jun; 25(2):309-13. PubMed ID: 4147131
[No Abstract] [Full Text] [Related]
33. Abnormalities of platelet function in hypertension and diabetes.
Hamet P; Skuherska R; Pang SC; Tremblay J
Hypertension; 1985; 7(6 Pt 2):II135-42. PubMed ID: 3000939
[TBL] [Abstract][Full Text] [Related]
34. The effects of flavonoids on cyclic nucleotide phosphodiesterases.
Beretz A; Anton R; Cazenave JP
Prog Clin Biol Res; 1986; 213():281-96. PubMed ID: 3012580
[No Abstract] [Full Text] [Related]
35. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
Hagiwara M; Endo T; Kanayama T; Hidaka H
J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
Nemoz G; Prigent AF
Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
[No Abstract] [Full Text] [Related]
37. Cyclic nucleotides in platelet function.
Haslam RJ; Davidson MM; Fox JE; Lynham JA
Thromb Haemost; 1978 Oct; 40(2):232-40. PubMed ID: 216130
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
